N-Acetylcysteine Treatment May Compensate Motor Impairments through Dopaminergic Transmission Modulation in a Striatal 6-Hydroxydopamine Parkinson’s Disease Rat Model

Preventing degeneration and the loss of dopaminergic neurons (DAn) in the brain while mitigating motor symptoms remains a challenge in Parkinson’s Disease (PD) treatment development. In light of this, developing or repositioning potential disease-modifying approaches is imperative to achieve meaning...

Descripción completa

Detalles Bibliográficos
Autores principales: Caridade-Silva, Rita, Araújo, Bruna, Martins-Macedo, Joana, Teixeira, Fábio G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295771/
https://www.ncbi.nlm.nih.gov/pubmed/37371987
http://dx.doi.org/10.3390/antiox12061257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295771/
https://www.ncbi.nlm.nih.gov/pubmed/37371987
http://dx.doi.org/10.3390/antiox12061257

Ejemplares similares